Get the Stockscreener App
2.61
1.88%
-0.05
After Hours:
2.62
0.01
+0.38%
Kodiak Sciences Inc stock is traded at $2.61, with a volume of 138.71K.
It is down -1.88% in the last 24 hours and up +3.98% over the past month.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
See More
Previous Close:
$2.66
Open:
$2.65
24h Volume:
138.71K
Relative Volume:
0.61
Market Cap:
$136.27M
Revenue:
-
Net Income/Loss:
$-260.49M
P/E Ratio:
-0.4579
EPS:
-5.7
Net Cash Flow:
$-195.61M
1W Performance:
+3.98%
1M Performance:
+3.98%
6M Performance:
-50.38%
1Y Performance:
+45.00%
1-Day Range:
$2.57
$2.74
1-Week Range:
$2.33
$2.80
52-Week Range:
$1.37
$7.77
Kodiak Sciences Inc Stock (KOD) Company Profile
Name
Kodiak Sciences Inc
Sector
Industry
Phone
650-281-0850
Address
1200 PAGE MILL RD, PALO ALTO, CA
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-27-23 | Downgrade | UBS | Buy → Neutral |
| Jul-25-23 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-25-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-24-23 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jul-24-23 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-22 | Initiated | CapitalOne | Overweight |
| Aug-02-22 | Downgrade | Citigroup | Neutral → Sell |
| Feb-24-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-21 | Upgrade | ROTH Capital | Neutral → Buy |
| Mar-12-21 | Initiated | Evercore ISI | Outperform |
| Mar-01-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-17-21 | Downgrade | ROTH Capital | Buy → Neutral |
| Jan-25-21 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-17-20 | Initiated | Berenberg | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Nov-30-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-13-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-31-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-03-20 | Initiated | Goldman | Buy |
| Feb-18-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-06-20 | Initiated | SunTrust | Buy |
| Jan-08-20 | Initiated | ROTH Capital | Buy |
| Jan-03-20 | Initiated | Jefferies | Buy |
| Dec-24-19 | Initiated | JP Morgan | Overweight |
| Oct-15-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-20-19 | Initiated | Chardan Capital Markets | Buy |
| Oct-29-18 | Initiated | Barclays | Overweight |
| Oct-29-18 | Initiated | BofA/Merrill | Buy |
| Oct-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Kodiak Sciences Inc Stock (KOD) Latest News
Kodiak Sciences (KOD) Price Target Increased by 25.00% to 5.10 - MSN
Retinal Disorder Treatment Market Share Report, Industry Share and Trends Analysis By 2033 - WhaTech
Retinal Biologics Market Advancements Highlighted by Size, Share Analysis And Forecast Report 2024 To 2033 - WhaTech
Goldman Sachs maintains sell rating on Kodiak Sciences stock By Investing.com - Investing.com South Africa
Goldman Sachs maintains sell rating on Kodiak Sciences stock - Investing.com
Kodiak Sciences (NASDAQ:KOD) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time - StockTitan
Psilocybin Equals or Exceeds SSRI Antidepressants at Easing Depression - 69News WFMZ-TV
Cataracts Gone Without Surgery? New Science Suggests It's Possible - 69News WFMZ-TV
Could Antidepressants Give Memory a Boost? - 69News WFMZ-TV
We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully - Yahoo Finance
Stock market today: Wall Street stays stuck in place as it counts down to a rate cut - 69News WFMZ-TV
Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City - StockTitan
Health Beat: Giving hope to melanoma patients - 69News WFMZ-TV
Google says it will rethink its plans for a big data center in Chile over water worries - 69News WFMZ-TV
More Cancer Cases in Areas Where Incarceration Rates Are High: Study - 69News WFMZ-TV
Logan Paul and MrBeast launch a Lunchables competitor that they say is healthy - 69News WFMZ-TV
A Few Cups of Coffee Per Day Might Help Your Heart - 69News WFMZ-TV
Nearly 2 in 5 Americans at peak stress levels - 69News WFMZ-TV
Why Is Kodiak Sciences (KOD) Down 8.1% Since Last Earnings Report? - MSN
Pivotal Research Initiates Coverage of TKO Group Holdings (TKO) with Buy Recommendation - MSN
Why Is Kodiak Sciences (KOD) Down 8.1% Since Last Earnings Report? - Yahoo Finance
Acadian Asset Management LLC Raises Stake in Kodiak Sciences Inc. (NASDAQ:KOD) - MarketBeat
Rimini Street, Inc. (NASDAQ:RMNI) Shares Bought by Acadian Asset Management LLC - Defense World
Strategic Financial Concepts LLC Purchases New Position in Prosperity Bancshares, Inc. (NYSE:PB) - Defense World
Acadian Asset Management LLC Sells 295,944 Shares of Juniper Networks, Inc. (NYSE:JNPR) - Defense World
Data Storage (NASDAQ:DTST) Stock Quotes, Forecast and News Summary - Benzinga
AMD Drugs Market Size, Share, Growth Analysis, and Report 2024-2031 - openPR
Kodiak Sciences Inc. (NASDAQ:KOD) to Post Q3 2024 Earnings of ($0.88) Per Share, HC Wainwright Forecasts - MarketBeat
Zacks Research Comments on Itron, Inc.’s FY2024 Earnings (NASDAQ:ITRI) - Defense World
Zacks Research Weighs in on Kodiak Sciences Inc.'s FY2024 Earnings (NASDAQ:KOD) - MarketBeat
HC Wainwright Begins Coverage on Kodiak Sciences (NASDAQ:KOD) - MarketBeat
Cosa Resources begins drilling at Canadian uranium project - Mining Technology
Retinal Vein Occlusion Market to Grow Positively at a Paltry CAGR - openPR
Abrdn Global Infrastructure Income Fund (NYSE:ASGI) Trading Down 0.7% - Defense World
Imperial Petroleum Inc. (NASDAQ:IMPP) Short Interest Update - Defense World
Inhibrx, Inc. (NASDAQ:INBX) Short Interest Update - Defense World
Jet.AI Inc. (NASDAQ:JTAIW) Sees Significant Increase in Short Interest - Defense World
9F Inc. (NASDAQ:JFU) Sees Large Increase in Short Interest - Defense World
Finward Bancorp (OTCMKTS:FNWD) Stock Price Up 0.5% - Defense World
TC Bancshares (NASDAQ:TCBC) Trading Down 0.8% - Defense World
Are Smart Investors Making the Right Decision? Kodiak Sciences Inc (KOD) - SETE News
KOD overperforms with a 1.21 increase in share price - US Post News
Kodiak Sciences Inc. (NASDAQ:KOD) Sees Significant Decline in Short Interest - MarketBeat
Retinal Vein Occlusion Market 2024 : Global Industry Trends, Share, Size, Growth, Opportunity And Forecast ... - WhaTech
Diabetic Retinopathy Market Growth to Accelerate in Forecast - openPR
Age Related Macular Degeneration Market to Grow Positively at - openPR
FY2024 EPS Estimates for Kodiak Sciences Inc. (NASDAQ:KOD) Lifted by Analyst - MarketBeat
Chardan Capital Equities Analysts Increase Earnings Estimates for Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World
Kodiak (KOD) Q2 Loss Narrower Than Expected, Pipeline in Focus - Zacks Investment Research
Vanguard Group Inc. Buys 10,978 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World
Kodiak Sciences Inc Stock (KOD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):